A Novel Selective Inhibitor JBI-589 Targets PAD4-Mediated Neutrophil Migration to Suppress Tumor Progression. Deng H, Lin C, Garcia-Gerique L, Fu S, et al. Cancer Res 2022;82:3561-3572.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Deng H, Lin C, Garcia-Gerique L, Fu S, et al. A Novel Selective Inhibitor JBI-589 Targets PAD4-Mediated Neutrophil Migration to Suppress Tumor Progression. Cancer Res 2022;82:3561-3572.
PMID: 36069973